Arthur Klausner

496 total citations
71 papers, 349 citations indexed

About

Arthur Klausner is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Arthur Klausner has authored 71 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 8 papers in Molecular Biology and 6 papers in Reproductive Medicine. Recurrent topics in Arthur Klausner's work include Biotechnology and Related Fields (14 papers), Science, Research, and Medicine (6 papers) and Biomedical and Engineering Education (4 papers). Arthur Klausner is often cited by papers focused on Biotechnology and Related Fields (14 papers), Science, Research, and Medicine (6 papers) and Biomedical and Engineering Education (4 papers). Arthur Klausner collaborates with scholars based in United States. Arthur Klausner's co-authors include Jeffrey L. Fox, Todd T. Talley, Mohammed Milhem, Jennifer Van Brunt, Brian A. Van Tine, Richard D. Olson, Gerald M. Walsh, Mark Agulnik, Harvey Bialy and Vivian Lee and has published in prestigious journals such as Nature Biotechnology, Cancer Medicine and Bio/Technology.

In The Last Decade

Arthur Klausner

67 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arthur Klausner United States 10 202 53 46 42 40 71 349
R. Fleer United States 7 258 1.3× 38 0.7× 24 0.5× 43 1.0× 39 1.0× 11 323
K. T. Atherton United Kingdom 8 194 1.0× 38 0.7× 62 1.3× 41 1.0× 29 0.7× 15 308
Robert A. Goldman United States 6 236 1.2× 30 0.6× 26 0.6× 52 1.2× 35 0.9× 8 367
Ruye Xing United States 9 286 1.4× 39 0.7× 18 0.4× 33 0.8× 33 0.8× 9 399
Hideyuki Ohi Japan 12 340 1.7× 68 1.3× 21 0.5× 40 1.0× 65 1.6× 14 422
Toyomasa Hatakeyama Japan 11 223 1.1× 47 0.9× 30 0.7× 19 0.5× 105 2.6× 21 358
Otmar Hohenwarter Pakistan 9 241 1.2× 30 0.6× 15 0.3× 33 0.8× 42 1.1× 13 347
Hsiu‐Ping Lin Taiwan 12 248 1.2× 40 0.8× 62 1.3× 29 0.7× 46 1.1× 24 375
Shinobu Kuwae Japan 10 382 1.9× 88 1.7× 24 0.5× 44 1.0× 70 1.8× 15 439
Eric McCairns Australia 10 200 1.0× 26 0.5× 45 1.0× 19 0.5× 11 0.3× 16 330

Countries citing papers authored by Arthur Klausner

Since Specialization
Citations

This map shows the geographic impact of Arthur Klausner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Klausner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Klausner more than expected).

Fields of papers citing papers by Arthur Klausner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur Klausner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Klausner. The network helps show where Arthur Klausner may publish in the future.

Co-authorship network of co-authors of Arthur Klausner

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur Klausner. A scholar is included among the top collaborators of Arthur Klausner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur Klausner. Arthur Klausner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klausner, Arthur, et al.. (2022). So you want to start a biotech company. Nature Biotechnology. 40(3). 296–300. 5 indexed citations
2.
Tine, Brian A. Van, Mark Agulnik, Richard D. Olson, et al.. (2019). A phase II clinical study of 13‐deoxy, 5‐iminodoxorubicin (GPX‐150) with metastatic and unresectable soft tissue sarcoma. Cancer Medicine. 8(6). 2994–3003. 9 indexed citations
3.
Klausner, Arthur. (2005). Biotech venture capital—it's not too late to be early. Nature Biotechnology. 23(4). 417–418. 4 indexed citations
4.
Klausner, Arthur. (2005). Mind the (biomedical funding) gap. Nature Biotechnology. 23(10). 1217–1218. 2 indexed citations
5.
Klausner, Arthur. (1988). Adjuvants: A Real Shot in the Arm for Recombinant Vaccines. Nature Biotechnology. 6(7). 773–777. 11 indexed citations
6.
Klausner, Arthur, et al.. (1988). Growth Factors Speed Wound Healing. Nature Biotechnology. 6(1). 25–30. 21 indexed citations
7.
Klausner, Arthur & Jeffrey L. Fox. (1988). Museum Exhibits Both Educate and Confound. Nature Biotechnology. 6(3). 246–247. 12 indexed citations
8.
Klausner, Arthur. (1988). What's Hot in Start-Ups. Nature Biotechnology. 6(6). 663–670. 2 indexed citations
9.
Klausner, Arthur. (1987). ‘Second Antibodies’ Lend a Hand in Imaging. Nature Biotechnology. 5(6). 533–533. 1 indexed citations
10.
Klausner, Arthur. (1987). The TNF Waiting Game. Nature Biotechnology. 5(4). 335–339. 5 indexed citations
11.
Klausner, Arthur. (1987). Many Angles to Competitive Analysis. Nature Biotechnology. 5(11). 1129–1129. 2 indexed citations
12.
Klausner, Arthur. (1987). Handicapping Pharmaceuticals' Prospects. Nature Biotechnology. 5(2). 116–116. 1 indexed citations
13.
Klausner, Arthur. (1987). Tissue Culture for Improved Toxicology. Nature Biotechnology. 5(8). 779–786. 6 indexed citations
14.
Klausner, Arthur. (1986). TNF Trials Show Little Efficacy. Nature Biotechnology. 4(12). 1044–1044. 1 indexed citations
15.
Klausner, Arthur. (1986). AgBiotech Products Hit Regulatory Snags. Nature Biotechnology. 4(5). 381–381. 2 indexed citations
16.
Klausner, Arthur. (1986). USDA Sows Seeds for its Future. Nature Biotechnology. 4(1). 27–31. 1 indexed citations
17.
Klausner, Arthur. (1985). Building for Success in Phenylalanine. Nature Biotechnology. 3(4). 301–307. 34 indexed citations
18.
Klausner, Arthur. (1985). Biotech stocks continue to lag. Nature Biotechnology. 3(1). 24–25. 4 indexed citations
19.
Klausner, Arthur. (1985). Equipment Funding: Shared Instrument Grants Find Varied Uses. Nature Biotechnology. 3(4). 292–295. 1 indexed citations
20.
Klausner, Arthur. (1984). Analysts Predicting Biotech Stock Rises for 1984. Nature Biotechnology. 2(1). 16–20. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Fleer Breakdown of academic impact, for papers by K. T. Atherton Breakdown of academic impact, for papers by Robert A. Goldman Breakdown of academic impact, for papers by Ruye Xing Breakdown of academic impact, for papers by Hideyuki Ohi Breakdown of academic impact, for papers by Toyomasa Hatakeyama Breakdown of academic impact, for papers by Otmar Hohenwarter Breakdown of academic impact, for papers by Hsiu‐Ping Lin Breakdown of academic impact, for papers by Shinobu Kuwae Breakdown of academic impact, for papers by Eric McCairns
Rankless by CCL
2026